Pei Jai Michael Ho
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Infarction | 17 | 2015 | 1134 | 2.440 |
Why?
| Medication Adherence | 13 | 2015 | 575 | 1.990 |
Why?
| Antihypertensive Agents | 8 | 2015 | 465 | 1.730 |
Why?
| Hospitals, Veterans | 7 | 2015 | 260 | 1.590 |
Why?
| Hypertension | 12 | 2015 | 1245 | 1.580 |
Why?
| Percutaneous Coronary Intervention | 8 | 2015 | 535 | 1.300 |
Why?
| Secondary Prevention | 5 | 2015 | 257 | 1.200 |
Why?
| Ticlopidine | 5 | 2014 | 71 | 1.150 |
Why?
| United States Department of Veterans Affairs | 10 | 2015 | 564 | 1.120 |
Why?
| Platelet Aggregation Inhibitors | 7 | 2015 | 425 | 1.040 |
Why?
| Blood Pressure | 7 | 2012 | 1713 | 1.000 |
Why?
| Hospital Costs | 2 | 2015 | 114 | 0.970 |
Why?
| Acute Coronary Syndrome | 3 | 2015 | 268 | 0.880 |
Why?
| Veterans | 9 | 2015 | 1203 | 0.810 |
Why?
| Registries | 14 | 2015 | 2020 | 0.720 |
Why?
| Coronary Artery Disease | 7 | 2015 | 695 | 0.700 |
Why?
| Adrenergic beta-Antagonists | 5 | 2015 | 334 | 0.640 |
Why?
| Practice Patterns, Physicians' | 4 | 2015 | 1267 | 0.630 |
Why?
| beta-Alanine | 2 | 2015 | 22 | 0.620 |
Why?
| Antithrombins | 2 | 2015 | 57 | 0.600 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2015 | 228 | 0.580 |
Why?
| Benzimidazoles | 2 | 2015 | 142 | 0.570 |
Why?
| Follow-Up Studies | 16 | 2015 | 4768 | 0.570 |
Why?
| Patient Identification Systems | 2 | 2015 | 20 | 0.560 |
Why?
| Stroke | 2 | 2014 | 1090 | 0.510 |
Why?
| Aged | 32 | 2015 | 20495 | 0.510 |
Why?
| Drug Resistance | 2 | 2012 | 169 | 0.500 |
Why?
| Andropause | 1 | 2014 | 7 | 0.490 |
Why?
| Middle Aged | 35 | 2015 | 28563 | 0.490 |
Why?
| Exercise Test | 3 | 2015 | 588 | 0.480 |
Why?
| United States | 23 | 2015 | 13272 | 0.470 |
Why?
| Cardiovascular Agents | 1 | 2015 | 140 | 0.470 |
Why?
| Mineralocorticoid Receptor Antagonists | 1 | 2013 | 57 | 0.470 |
Why?
| Pharmacy Service, Hospital | 1 | 2014 | 88 | 0.460 |
Why?
| Fibrinolytic Agents | 2 | 2015 | 257 | 0.460 |
Why?
| Cardiotonic Agents | 1 | 2014 | 133 | 0.460 |
Why?
| Time Factors | 15 | 2015 | 6682 | 0.450 |
Why?
| Quality Assurance, Health Care | 1 | 2015 | 362 | 0.440 |
Why?
| Quality Indicators, Health Care | 2 | 2012 | 315 | 0.430 |
Why?
| Retrospective Studies | 19 | 2015 | 13433 | 0.420 |
Why?
| Hospital Mortality | 3 | 2015 | 901 | 0.410 |
Why?
| Postoperative Complications | 2 | 2015 | 2301 | 0.410 |
Why?
| Diagnostic Techniques, Cardiovascular | 1 | 2011 | 17 | 0.410 |
Why?
| Male | 41 | 2015 | 59639 | 0.400 |
Why?
| Patient Discharge | 4 | 2014 | 842 | 0.400 |
Why?
| Patient Compliance | 3 | 2015 | 561 | 0.390 |
Why?
| Testosterone | 1 | 2014 | 353 | 0.380 |
Why?
| Patient Education as Topic | 3 | 2015 | 717 | 0.380 |
Why?
| Female | 40 | 2015 | 63629 | 0.360 |
Why?
| Practice Guidelines as Topic | 3 | 2015 | 1519 | 0.360 |
Why?
| Physician-Patient Relations | 1 | 2014 | 509 | 0.340 |
Why?
| Hospitalization | 3 | 2015 | 1914 | 0.340 |
Why?
| Cohort Studies | 9 | 2015 | 5294 | 0.330 |
Why?
| Prosthesis Implantation | 1 | 2010 | 148 | 0.330 |
Why?
| Cardiovascular Diseases | 4 | 2015 | 1859 | 0.320 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2015 | 410 | 0.290 |
Why?
| Humans | 46 | 2015 | 122796 | 0.290 |
Why?
| Risk Assessment | 6 | 2015 | 3213 | 0.290 |
Why?
| Coronary Artery Bypass | 4 | 2014 | 226 | 0.280 |
Why?
| Risk Factors | 13 | 2015 | 9381 | 0.270 |
Why?
| Treatment Outcome | 11 | 2015 | 9692 | 0.270 |
Why?
| Atrial Fibrillation | 3 | 2015 | 392 | 0.270 |
Why?
| Longitudinal Studies | 6 | 2015 | 2599 | 0.270 |
Why?
| Drug-Eluting Stents | 4 | 2014 | 79 | 0.260 |
Why?
| Chi-Square Distribution | 4 | 2015 | 551 | 0.260 |
Why?
| Markov Chains | 2 | 2015 | 130 | 0.250 |
Why?
| Odds Ratio | 4 | 2015 | 1043 | 0.240 |
Why?
| Aspirin | 3 | 2015 | 344 | 0.230 |
Why?
| Primary Prevention | 2 | 2015 | 212 | 0.220 |
Why?
| Intermittent Claudication | 2 | 2015 | 112 | 0.210 |
Why?
| Guideline Adherence | 3 | 2015 | 560 | 0.210 |
Why?
| Multivariate Analysis | 3 | 2015 | 1531 | 0.210 |
Why?
| Incidence | 5 | 2015 | 2527 | 0.200 |
Why?
| Logistic Models | 4 | 2015 | 1995 | 0.200 |
Why?
| Prognosis | 6 | 2014 | 3563 | 0.190 |
Why?
| Prescriptions | 2 | 2010 | 67 | 0.190 |
Why?
| Patient Selection | 2 | 2015 | 717 | 0.190 |
Why?
| Coronary Angiography | 4 | 2014 | 336 | 0.180 |
Why?
| Aged, 80 and over | 5 | 2015 | 6845 | 0.180 |
Why?
| Walking | 2 | 2015 | 435 | 0.170 |
Why?
| Rehabilitation | 2 | 2015 | 17 | 0.170 |
Why?
| Proportional Hazards Models | 4 | 2014 | 1184 | 0.160 |
Why?
| Hospitals | 2 | 2014 | 633 | 0.160 |
Why?
| Survival Rate | 4 | 2015 | 1810 | 0.160 |
Why?
| Dabigatran | 2 | 2015 | 29 | 0.160 |
Why?
| Telemedicine | 3 | 2015 | 691 | 0.150 |
Why?
| Hemorrhage | 4 | 2014 | 663 | 0.150 |
Why?
| Dose-Response Relationship, Drug | 2 | 2012 | 1981 | 0.150 |
Why?
| Peripheral Arterial Disease | 2 | 2015 | 398 | 0.150 |
Why?
| Cause of Death | 2 | 2015 | 389 | 0.140 |
Why?
| Adult | 8 | 2015 | 32385 | 0.140 |
Why?
| Recurrence | 2 | 2015 | 998 | 0.130 |
Why?
| Angiotensin II Type 1 Receptor Blockers | 1 | 2015 | 35 | 0.130 |
Why?
| Linear Models | 2 | 2015 | 854 | 0.130 |
Why?
| Digoxin | 1 | 2014 | 29 | 0.130 |
Why?
| Monte Carlo Method | 1 | 2015 | 149 | 0.130 |
Why?
| Angina Pectoris | 1 | 2014 | 72 | 0.120 |
Why?
| Consultants | 1 | 2014 | 13 | 0.120 |
Why?
| Early Medical Intervention | 1 | 2015 | 56 | 0.120 |
Why?
| Saphenous Vein | 1 | 2014 | 36 | 0.120 |
Why?
| Arterial Occlusive Diseases | 1 | 2014 | 81 | 0.120 |
Why?
| Gastrointestinal Hemorrhage | 1 | 2015 | 113 | 0.120 |
Why?
| Stents | 2 | 2014 | 491 | 0.120 |
Why?
| Drug Monitoring | 1 | 2015 | 189 | 0.120 |
Why?
| Observational Studies as Topic | 1 | 2014 | 91 | 0.120 |
Why?
| Veterans Health | 1 | 2015 | 167 | 0.110 |
Why?
| Community Health Services | 1 | 2015 | 216 | 0.110 |
Why?
| Mortality | 1 | 2015 | 317 | 0.110 |
Why?
| Myocardial Ischemia | 1 | 2014 | 267 | 0.110 |
Why?
| Program Evaluation | 2 | 2015 | 880 | 0.110 |
Why?
| Quality of Life | 2 | 2015 | 2457 | 0.110 |
Why?
| Health Services Needs and Demand | 1 | 2014 | 265 | 0.110 |
Why?
| Diuretics | 1 | 2012 | 78 | 0.110 |
Why?
| Patient Participation | 1 | 2015 | 371 | 0.100 |
Why?
| Pain Management | 1 | 2015 | 306 | 0.100 |
Why?
| Interprofessional Relations | 1 | 2014 | 271 | 0.100 |
Why?
| Colorado | 5 | 2015 | 4325 | 0.100 |
Why?
| Outpatients | 1 | 2014 | 336 | 0.100 |
Why?
| Coronary Disease | 1 | 2013 | 372 | 0.100 |
Why?
| Ambulatory Care | 1 | 2015 | 497 | 0.100 |
Why?
| Exercise Therapy | 1 | 2015 | 375 | 0.100 |
Why?
| Sodium Chloride Symporter Inhibitors | 1 | 2010 | 13 | 0.100 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 2011 | 66 | 0.100 |
Why?
| Decision Support Techniques | 1 | 2014 | 392 | 0.090 |
Why?
| Cardiology | 1 | 2013 | 338 | 0.090 |
Why?
| Sex Factors | 2 | 2013 | 1860 | 0.090 |
Why?
| Medical Records Systems, Computerized | 1 | 2010 | 92 | 0.090 |
Why?
| Survival Analysis | 2 | 2010 | 1325 | 0.090 |
Why?
| Heart Failure | 2 | 2014 | 2114 | 0.090 |
Why?
| Anticoagulants | 1 | 2014 | 589 | 0.090 |
Why?
| Health Status | 1 | 2014 | 758 | 0.090 |
Why?
| Referral and Consultation | 1 | 2014 | 669 | 0.090 |
Why?
| Medication Therapy Management | 1 | 2010 | 73 | 0.090 |
Why?
| Disability Evaluation | 1 | 2011 | 291 | 0.090 |
Why?
| Kaplan-Meier Estimate | 1 | 2011 | 884 | 0.080 |
Why?
| Chemotherapy, Adjuvant | 1 | 2010 | 369 | 0.080 |
Why?
| Clinical Protocols | 1 | 2010 | 248 | 0.080 |
Why?
| Drug Therapy, Combination | 1 | 2011 | 988 | 0.080 |
Why?
| Prospective Studies | 4 | 2015 | 6704 | 0.080 |
Why?
| Health Services Accessibility | 1 | 2014 | 813 | 0.080 |
Why?
| Caregivers | 1 | 2014 | 723 | 0.080 |
Why?
| Combined Modality Therapy | 1 | 2011 | 1174 | 0.080 |
Why?
| Kidney Diseases | 1 | 2011 | 446 | 0.070 |
Why?
| Electronic Health Records | 1 | 2014 | 842 | 0.070 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2014 | 770 | 0.070 |
Why?
| Surveys and Questionnaires | 3 | 2015 | 4882 | 0.070 |
Why?
| Confidence Intervals | 2 | 2015 | 339 | 0.060 |
Why?
| Primary Health Care | 1 | 2014 | 1625 | 0.060 |
Why?
| Pharmacists | 2 | 2015 | 245 | 0.050 |
Why?
| Blood Pressure Determination | 2 | 2010 | 135 | 0.040 |
Why?
| Recovery of Function | 2 | 2015 | 610 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 2015 | 1947 | 0.040 |
Why?
| Comorbidity | 2 | 2014 | 1600 | 0.040 |
Why?
| Age Factors | 2 | 2015 | 3114 | 0.030 |
Why?
| Intention to Treat Analysis | 1 | 2015 | 72 | 0.030 |
Why?
| Emotional Intelligence | 1 | 2014 | 8 | 0.030 |
Why?
| Bioprosthesis | 1 | 2014 | 37 | 0.030 |
Why?
| Angina, Unstable | 1 | 2014 | 82 | 0.030 |
Why?
| Pharmacoepidemiology | 1 | 2014 | 22 | 0.030 |
Why?
| Risk Reduction Behavior | 1 | 2015 | 205 | 0.030 |
Why?
| Metals | 1 | 2014 | 116 | 0.030 |
Why?
| Anti-Arrhythmia Agents | 1 | 2014 | 132 | 0.030 |
Why?
| Disease Progression | 2 | 2011 | 2546 | 0.030 |
Why?
| Exercise Tolerance | 1 | 2015 | 245 | 0.030 |
Why?
| Propensity Score | 1 | 2014 | 253 | 0.030 |
Why?
| Diabetic Angiopathies | 1 | 2015 | 270 | 0.030 |
Why?
| Needs Assessment | 1 | 2014 | 345 | 0.030 |
Why?
| Feasibility Studies | 1 | 2015 | 780 | 0.030 |
Why?
| Counseling | 1 | 2015 | 364 | 0.030 |
Why?
| Self Care | 1 | 2014 | 360 | 0.030 |
Why?
| Drug Prescriptions | 1 | 2013 | 271 | 0.030 |
Why?
| Drug Utilization | 1 | 2012 | 183 | 0.020 |
Why?
| Sickness Impact Profile | 1 | 2011 | 53 | 0.020 |
Why?
| Hospitals, Military | 1 | 2011 | 39 | 0.020 |
Why?
| Social Support | 1 | 2014 | 547 | 0.020 |
Why?
| Ventricular Outflow Obstruction | 1 | 2010 | 38 | 0.020 |
Why?
| Angiotensin Receptor Antagonists | 1 | 2010 | 93 | 0.020 |
Why?
| Telephone | 1 | 2011 | 160 | 0.020 |
Why?
| Pilot Projects | 1 | 2015 | 1477 | 0.020 |
Why?
| Computer Simulation | 1 | 2014 | 945 | 0.020 |
Why?
| Adaptation, Psychological | 1 | 2014 | 569 | 0.020 |
Why?
| Qualitative Research | 1 | 2014 | 950 | 0.020 |
Why?
| California | 1 | 2010 | 387 | 0.020 |
Why?
| Age of Onset | 1 | 2010 | 479 | 0.020 |
Why?
| Patient Readmission | 1 | 2014 | 691 | 0.020 |
Why?
| Medicare | 1 | 2013 | 767 | 0.020 |
Why?
| Glomerular Filtration Rate | 1 | 2011 | 697 | 0.020 |
Why?
| Prevalence | 1 | 2014 | 2442 | 0.020 |
Why?
| Cardiac Catheterization | 1 | 2010 | 577 | 0.020 |
Why?
| Health Behavior | 1 | 2011 | 731 | 0.020 |
Why?
| Quality of Health Care | 1 | 2010 | 631 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2015 | 4734 | 0.020 |
Why?
| Kidney | 1 | 2011 | 1355 | 0.010 |
Why?
| Exercise | 1 | 2014 | 1743 | 0.010 |
Why?
| Young Adult | 1 | 2011 | 11094 | 0.010 |
Why?
|
|
Ho's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|